Sorafenib With Doxorubicin Augments Cytotoxicity To Renal Cell Cancer Through PERK Inhibition

Below is result for Sorafenib With Doxorubicin Augments Cytotoxicity To Renal Cell Cancer Through PERK Inhibition in PDF format. You can download or read online all document for free, but please respect copyrighted ebooks. This site does not host PDF files, all document are the property of their respective owners.

技師長承認 委員会審査 記録作成 Q31 F1 論文記録

Sensitivity of Doxorubicin-Resistant Cells to Sorafenib: Sorafenib with Doxorubicin Augments Cytotoxicity to Renal Cell Cancer through Perk Inhibition. Int J

Sorafenib with doxorubicin augments cytotoxicity to renal

Sorafenib with doxorubicin augments cytotoxicity to renal cell cancer through PERK inhibition MASAKI SHIOTA1, MASATOSHI ETO3, AKIRA YOKOMIZO1, YASUHIRO TADA1, ARIO TAKEUCHI1, DAISUKE MASUBUCHI1, JUNICHI INOKUCHI1, KATSUNORI TATSUGAMI1, KENTARO KUROIWA1, TAKESHI UCHIUMI2, NARIHITO SEKI1 and SEIJI NAITO1